All Stories

  1. The effect of levocarnitine supplementation on dialysis-related hypotension: A systematic review, meta-analysis, and trial sequential analysis
  2. Correlation between clinical and pathological features of cutaneous calciphylaxis
  3. Medication Prescription Patterns for Secondary Hyperparathyroidism
  4. Calciphylaxis-as a drug induced adverse event
  5. Characterization and Correction of Olfactory Deficits in Kidney Disease
  6. Vitamin K–Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis
  7. Calciphylaxis in peritoneal dialysis patients: a single center cohort study
  8. Interventions for lowering plasma homocysteine levels in dialysis patients
  9. We Do Too Many Parathyroidectomies for Calciphylaxis
  10. A Nationally Representative Study of Calcific Uremic Arteriolopathy Risk Factors
  11. Mild prolonged chronic hyponatremia and risk of hip fracture in the elderly
  12. Optimal management of bone mineral disorders in chronic kidney disease and end stage renal disease
  13. Hemodialysis Complications
  14. The Role of Bone Scintigraphy in the Diagnosis of Calciphylaxis
  15. Multidisciplinary approach to calcific uremic arteriolopathy
  16. Raman spectroscopy for label-free identification of calciphylaxis
  17. Calciphylaxis: Risk Factors, Diagnosis, and Treatment
  18. Homocysteine lowering in kidney transplant systematic review
  19. Nutritional D supplementation in dialysis
  20. Calciphylaxis: A Rare But Fatal Delayed Complication of Roux-en-Y Gastric Bypass Surgery
  21. Quantifying a Rare Disease in Administrative Data: The Example of Calciphylaxis
  22. Vitamin D and chronic kidney disease–mineral bone disease (CKD–MBD)
  23. HMG CoA reductase inhibitors (statins) for kidney transplant recipients
  24. Vitamin D receptor activation: cardiovascular and renal implications
  25. Hyponatremia, Mineral Metabolism, and Mortality in Incident Maintenance Hemodialysis Patients: A Cohort Study
  26. HMG CoA reductase inhibitors (statins) for dialysis patients
  27. Intralesional Sodium Thiosulfate for the Treatment of Calciphylaxis
  28. Is sodium thiosulfate the right treatment for calciphylaxis?
  29. Shining light on vitamin D trials in chronic kidney disease
  30. Thyroid hormones for acute kidney injury
  31. Natriuretic Peptides in the Management of Solid Organ Transplantation Associated Acute Kidney Injury: A Systematic Review and Meta-Analysis
  32. Statin Use and Calcific Uremic Arteriolopathy: A Matched Case-Control Study
  33. In Reply to “Calcidiol Deficiency in CKD Patients: The Role of Reduced Liver Synthesis”
  34. Ergocalciferol and Cholecalciferol in CKD
  35. The effect of folic acid based homocysteine lowering on cardiovascular events in people with kidney disease: systematic review and meta-analysis
  36. Diuretics in Acute Kidney Injury
  37. Reply
  38. Vitamin D, Hypertension, Left Ventricular Hypertrophy, and Diastolic Dysfunction
  39. EXTERNAL MULTICENTER VALIDATION OF THE MEHRAN RISK SCORE FOR CONTRAST-INDUCED NEPHROPATHY
  40. Mortality and Serum Sodium: Do Patients Die from or with Hyponatremia?
  41. Nutritional vitamin D in dialysis patients: what to D-iscern?
  42. Péptido natriurético auricular para la prevención y el
  43. Prevention and Treatment of Acute Kidney Injury in Patients Undergoing Cardiac Surgery: A Systematic Review
  44. Atrial natriuretic peptide for preventing and treating acute kidney injury
  45. Off-Pump Coronary Artery Bypass Surgery and Acute Kidney Injury: A Meta-analysis of Randomized and Observational Studies
  46. HMG CoA reductase inhibitors (statins) for dialysis patients
  47. Aldosterone antagonists for preventing the progression of chronic kidney disease
  48. The Treatment of Hyponatremia
  49. HMG CoA reductase inhibitors (statins) for dialysis patients
  50. HMG CoA reductase inhibitors (statins) for kidney transplant recipients
  51. Interventions for lowering plasma homocysteine levels in dialysis patients
  52. The Role of Natriuretic Peptide Administration in Cardiovascular Surgery–Associated Renal Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  53. Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease
  54. Aldosterone Antagonists for Preventing the Progression of Chronic Kidney Disease: A Systematic Review and Meta-analysis
  55. Atrial Natriuretic Peptide for Management of Acute Kidney Injury: A Systematic Review and Meta-analysis
  56. HMG CoA reductase inhibitors (statins) for kidney transplant recipients
  57. N-Acetylcysteine in Cardiovascular-Surgery–Associated Renal Failure: A Meta-Analysis
  58. Lack of Permanent Access in Late Referrals and Its Implications: Not To Be Forgotten
  59. Hospitalist Care and Length of Stay in Patients With Hip Fracture: A Systematic Review
  60. Calciphylaxis from Nonuremic Causes: A Systematic Review
  61. 185: Sarcoidosis “Unmasked”
  62. 113: Prevention of Contrast Nephropathy: Are Practice Patterns Congruent With Current Recommendations?
  63. 184: Calciphylaxis from Non-Uremic Etiologies: A Systematic Review
  64. 186: Thyroxine for Acute Kidney Injury in Humans: A Systematic Review
  65. Aldosterone antagonists for preventing the progression of chronic kidney disease
  66. Prevalence and Predictors of Lack of Permanent Vascular Access in Early Referrals
  67. Effectiveness of Hospitalist Involvement in Hip Fracture Management Questioned
  68. An Unusual Case of Nonhealing Leg Ulcer in a Diabetic Patient
  69. Thyroxine for acute kidney injury
  70. Referral to Nephrologists for Chronic Kidney Disease Care: Is Non-Diabetic Kidney Disease Ignored?
  71. Timely Referral Alone May Not Be Enough for Patients With Chronic Kidney Disease
  72. Timely Referral Alone May Not Be Enough for Patients With Chronic Kidney Disease
  73. Atypical Presentation of Crohn Disease in an Asian-Indian Patient
  74. Educational Half Day
  75. Metastatic primary peritoneal carcinoma presenting as tension hydrothorax
  76. Atrial natriuretic peptide for preventing and treating acute renal failure